688076 诺泰生物
已收盘 04-30 15:00:00
资讯
新帖
简况
非酒精性脂肪性肝炎(NASH)概念盘中跳水,诺泰生物跌0.88%
自选股智能写手 · 04-26
非酒精性脂肪性肝炎(NASH)概念盘中跳水,诺泰生物跌0.88%
北向资金4月25日净卖出诺泰生物34.22万股 连续5日减持
自选股智能写手 · 04-26
北向资金4月25日净卖出诺泰生物34.22万股 连续5日减持
诺泰生物(688076)季报点评:收入超市场预期 自主产品放量带动业绩增长 多肽业务弹性大
国盛证券 · 04-26
诺泰生物(688076)季报点评:收入超市场预期 自主产品放量带动业绩增长 多肽业务弹性大
北向资金4月23日净卖出诺泰生物35.53万股 连续3日减持
自选股智能写手 · 04-24
北向资金4月23日净卖出诺泰生物35.53万股 连续3日减持
诺泰生物获融资买入0.26亿元,近三日累计买入0.44亿元
金融界 · 04-24
诺泰生物获融资买入0.26亿元,近三日累计买入0.44亿元
诺泰生物(688076)2024年一季报简析:营收净利润同比双双增长,应收账款上升
证券之星 · 04-24
诺泰生物(688076)2024年一季报简析:营收净利润同比双双增长,应收账款上升
诺泰生物4月22日遭北向资金减持66.65万股
自选股智能写手 · 04-23
诺泰生物4月22日遭北向资金减持66.65万股
诺泰生物(688076)3月31日股东户数1万户,较上期减少3.67%
证券之星 · 04-22
诺泰生物(688076)3月31日股东户数1万户,较上期减少3.67%
诺泰生物:2024年第一季度净利润约6633万元
每日经济新闻 · 04-22
诺泰生物:2024年第一季度净利润约6633万元
图解诺泰生物一季报:第一季度单季净利润同比增215.65%
证券之星 · 04-22
图解诺泰生物一季报:第一季度单季净利润同比增215.65%
诺泰生物将于5月30日召开股东大会,共审议11项议案
金融界 · 04-22
诺泰生物将于5月30日召开股东大会,共审议11项议案
诺泰生物(688076.SH)发布一季度业绩,归母净利润6632.68万元,同比增长215.65%
智通财经 · 04-22
诺泰生物(688076.SH)发布一季度业绩,归母净利润6632.68万元,同比增长215.65%
诺泰生物04月22日主力资金流出544万元 连续5日减仓
自选股智能写手 · 04-22
诺泰生物04月22日主力资金流出544万元 连续5日减仓
北向资金4月16日净卖出诺泰生物22.81万股 连续3日减持
自选股智能写手 · 04-17
北向资金4月16日净卖出诺泰生物22.81万股 连续3日减持
减肥药概念盘中跳水,诺泰生物跌0.75%
自选股智能写手 · 04-16
减肥药概念盘中跳水,诺泰生物跌0.75%
诺泰生物(688076)多肽赛道龙头企业,下游需求强劲成长空间广阔
开源证券 · 04-15
诺泰生物(688076)多肽赛道龙头企业,下游需求强劲成长空间广阔
开源证券给予诺泰生物买入评级
每日经济新闻 · 04-15
开源证券给予诺泰生物买入评级
诺泰生物大幅上涨 近半年6家券商增持
智选洞察 · 04-12
诺泰生物大幅上涨 近半年6家券商增持
加载更多
公司概况
公司名称:
江苏诺泰澳赛诺生物制药股份有限公司
所属行业:
医药制造业
上市日期:
2021-05-20
主营业务:
江苏诺泰澳赛诺生物制药股份有限公司是一家聚焦多肽药物及小分子化药进行自主研发与定制研发生产相结合的生物医药企业。公司的主要产品为阿托伐他汀钙片、氨氯地平阿托伐他汀钙片、利拉鲁肽、司美格鲁肽、苯甲酸阿格列汀、比伐芦定、依替巴肽、醋酸兰瑞肽、醋酸奥曲肽、磷酸奥司他韦、胸腺法新、GLP-1/GIP/GCG受体多靶点激动剂1类新药、氟维司群。
发行价格:
15.57
{"stockData":{"symbol":"688076","market":"SH","secType":"STK","nameCN":"诺泰生物","latestPrice":56.03,"timestamp":1714460400000,"preClose":54.77,"halted":0,"volume":2884849,"delay":0,"floatShares":146000000,"shares":213000000,"eps":0.9769,"marketStatus":"已收盘","marketStatusCode":5,"change":1.26,"latestTime":"04-30 15:00:00","open":54.48,"high":56.6,"low":54.45,"amount":161000000,"amplitude":0.0393,"askPrice":56.04,"askSize":2,"bidPrice":56.03,"bidSize":208,"shortable":0,"etf":0,"ttmEps":0.9769,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":54.77,"symbolType":"stock_kcb","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":60.25,"lowLimit":49.29,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":213183800,"pbRate":5.66,"roa":"--","roe":"3.0%","epsLYR":0.76,"committee":0.34964,"marketValue":11945000000,"floatMarketCap":8201000000,"peRate":57.354899,"changeRate":0.023,"turnoverRate":0.0197,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-05-06。","afterMarket":{"amount":0,"volume":0,"close":56.03,"buyVolume":0,"sellVolume":0,"time":1714462439505,"indexStatus":"已收盘 04-30 15:30:00","preClose":54.77}},"requestUrl":"/m/hq/s/688076","defaultTab":"news","newsList":[{"id":"2430295343","title":"非酒精性脂肪性肝炎(NASH)概念盘中跳水,诺泰生物跌0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430295343","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430295343?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:52","pubTimestamp":1714096337,"startTime":"0","endTime":"0","summary":"04月26日,非酒精性脂肪性肝炎(NASH)概念盘中跳水,截至09点52分,非酒精性脂肪性肝炎(NASH)概念整体指数下跌0.53%,报1053.540点。从个股上来看,该概念的成分股中,诺泰生物跌0.88%,华东医药、微芯生物跌幅居前。从资金上来看,截止发稿,非酒精性脂肪性肝炎(NASH)概念主力净流入为-2974.62万,其中迈瑞医疗受到资金热捧,主力净流入1895.23万;拉长时间线来看,该板块近20日主力资金净流入-4.25亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042609521787e83f30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042609521787e83f30&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430295317","title":"北向资金4月25日净卖出诺泰生物34.22万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2430295317","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430295317?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:30","pubTimestamp":1714095036,"startTime":"0","endTime":"0","summary":"4月25日,北向资金减持诺泰生物34.22万股连续5日减持。截止当日收盘,沪股通共持有诺泰生物280.62万股,占流通股1.91%。沪股通减持金额前五个股分别为中微公司、传音控股、药明康德、北汽蓝谷、中国太保。诺泰生物近5个交易日上涨6.11%,沪股通累计减持178.30万股;近20个交易日下跌6.48%,沪股通累计减持6.63万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042609344787b13d77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042609344787b13d77&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430697092","title":"诺泰生物(688076)季报点评:收入超市场预期 自主产品放量带动业绩增长 多肽业务弹性大","url":"https://stock-news.laohu8.com/highlight/detail?id=2430697092","media":"国盛证券","top":-1,"share":"https://www.laohu8.com/m/news/2430697092?lang=zh_cn&edition=full","pubTime":"2024-04-26 07:54","pubTimestamp":1714089272,"startTime":"0","endTime":"0","summary":"收入为单季度最高,同比增长71%,超市场预期,我们认为主要系多肽原料药及制剂板块放量驱动。自主产品规模效应显现毛利率增加,公司在手现金充沛,研发投入加大。司美格鲁肽百亿美元市场持续增长,抢仿原料药积极布局。近年来全球范围内司美格鲁肽市场规模迅速扩张,根据诺和诺德年报,2023 年司美格鲁肽销售额同比增长52%。作为多肽上游优质企业,公司的司美格鲁肽原料药已于2021 年通过DMF 完整性评估,于2023 年12 月获批FA Letter。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260754418b54b02a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260754418b54b02a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429017638","title":"北向资金4月23日净卖出诺泰生物35.53万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2429017638","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429017638?lang=zh_cn&edition=full","pubTime":"2024-04-24 09:30","pubTimestamp":1713922231,"startTime":"0","endTime":"0","summary":"4月23日,北向资金减持诺泰生物35.53万股连续3日减持。截止当日收盘,沪股通共持有诺泰生物344.12万股,占流通股2.35%。沪股通减持金额前五个股分别为中国中免、国电南瑞、中国建筑、兆易创新、中国联通。诺泰生物近5个交易日上涨8.27%,沪股通累计减持90.69万股;近20个交易日下跌3.34%,沪股通累计增持77.49万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240935188b4cb3da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240935188b4cb3da&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429540127","title":"诺泰生物获融资买入0.26亿元,近三日累计买入0.44亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429540127","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2429540127?lang=zh_cn&edition=full","pubTime":"2024-04-24 08:14","pubTimestamp":1713917692,"startTime":"0","endTime":"0","summary":"4月23日,沪深两融数据显示,诺泰生物获融资买入额0.26亿元,居两市第254位,当日融资偿还额0.20亿元,净买入645.42万元。最近三个交易日,19日-23日,诺泰生物分别获融资买入0.02亿元、0.16亿元、0.26亿元。融券方面,当日融券卖出0.17万股,净卖出0.04万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240817258b4c785b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240817258b4c785b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429125574","title":"诺泰生物(688076)2024年一季报简析:营收净利润同比双双增长,应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2429125574","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429125574?lang=zh_cn&edition=full","pubTime":"2024-04-24 06:11","pubTimestamp":1713910270,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期诺泰生物发布2024年一季报。根据财报显示,本报告期中诺泰生物营收净利润同比双双增长,应收账款上升。截至本报告期末,公司营业总收入3.56亿元,同比上升71.02%,归母净利润6632.68万元,同比上升215.65%。具体财务指标见下表:证券之星价投圈财报分析工具显示:资产质量方面,公司应收账款体量较大。公司最新一期年度报表的现金流为正,经营性现金流比利润高太多,通常是好事,建议确认原因。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400011866.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429182536","title":"诺泰生物4月22日遭北向资金减持66.65万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429182536","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429182536?lang=zh_cn&edition=full","pubTime":"2024-04-23 09:30","pubTimestamp":1713835830,"startTime":"0","endTime":"0","summary":"4月22日,北向资金减持诺泰生物66.65万股。截止当日收盘,沪股通共持有诺泰生物379.64万股,占流通股2.59%。沪股通减持金额前五个股分别为农业银行、中国石化、XD万华化、药明康德、长江电力。诺泰生物近5个交易日上涨3.75%,沪股通累计减持77.97万股;近20个交易日下跌5.48%,沪股通累计增持121.18万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042309361887a37d71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042309361887a37d71&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429910399","title":"诺泰生物(688076)3月31日股东户数1万户,较上期减少3.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429910399","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429910399?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:05","pubTimestamp":1713776756,"startTime":"0","endTime":"0","summary":"证券之星消息,近日诺泰生物披露,截至2024年3月31日公司股东户数为9974.0户,较2月29日减少380.0户,减幅为3.67%。在医疗服务行业个股中,诺泰生物股东户数低于行业平均水平,截至3月31日,医疗服务行业平均股东户数为3.96万户。从股价来看,2024年2月29日至2024年3月31日,诺泰生物区间涨幅为4.49%,在此期间股东户数减少380.0户,减幅为3.67%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200019161.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429091243","title":"诺泰生物:2024年第一季度净利润约6633万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429091243","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2429091243?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:43","pubTimestamp":1713775416,"startTime":"0","endTime":"0","summary":"诺泰生物(SH 688076,收盘价:53.69元)4月22日晚间发布一季度业绩公告称,2024年第一季度营收约3.56亿元,同比增加71.02%;归属于上市公司股东的净利润约6633万元,同比增加215.65%。诺泰生物的董事长、总经理均是童梓权,男,54岁,学历背景为硕士。截至发稿,诺泰生物市值为114亿元。文章来源:每日经济新闻原标题:诺泰生物:2024年第一季度净利润约6633万元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042216492787a0a3c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042216492787a0a3c6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429791247","title":"图解诺泰生物一季报:第一季度单季净利润同比增215.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429791247","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429791247?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:43","pubTimestamp":1713775390,"startTime":"0","endTime":"0","summary":"证券之星消息,诺泰生物2024年一季报显示,公司主营收入3.56亿元,同比上升71.02%;归母净利润6632.68万元,同比上升215.65%;扣非净利润6539.85万元,同比上升179.69%;负债率39.01%,投资收益17.35万元,财务费用324.53万元,毛利率67.26%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200017316.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429912458","title":"诺泰生物将于5月30日召开股东大会,共审议11项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2429912458","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2429912458?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:36","pubTimestamp":1713774996,"startTime":"0","endTime":"0","summary":"金融界4月22日消息,诺泰生物发布公告,将于2024年5月30日召开年度股东大会,网络投票同日进行。股权登记日为5月23日,当日收市后持有诺泰生物股票的投资者可以参与投票。会议地点:浙江省杭州市余杭区文一西路1378号杭州师范大学科技园E座12楼会议室。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042216375187a0946c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042216375187a0946c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429911200","title":"诺泰生物(688076.SH)发布一季度业绩,归母净利润6632.68万元,同比增长215.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429911200","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429911200?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:19","pubTimestamp":1713773978,"startTime":"0","endTime":"0","summary":"智通财经APP讯,诺泰生物(688076.SH)发布2024 年第一季度报告,营业收入3.56亿元,同比增长71.02%;归属于上市公司股东的净利润6632.68万元,同比增长215.65%;归属于上市公司股东的扣除非经常性损益的净利润6539.85万元,同比增长179.69%;基本每股收益0.31元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106456.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429915750","title":"诺泰生物04月22日主力资金流出544万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2429915750","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429915750?lang=zh_cn&edition=full","pubTime":"2024-04-22 15:19","pubTimestamp":1713770362,"startTime":"0","endTime":"0","summary":"04月22日, 诺泰生物股价涨4.90%,报收53.69元,成交金额2.22亿元,换手率2.86%,振幅7.23%,量比1.22。诺泰生物今日主力资金净流出544万元,连续5日净流出,上一交易日主力净流出3183万元,今日环比减少82.91%。该股近5个交易日上涨3.75%,主力资金累计净流出5787万元;近20日主力资金累计净流出4.95亿元,其中净流出天数为17日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042215364787a031bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042215364787a031bd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428334830","title":"北向资金4月16日净卖出诺泰生物22.81万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2428334830","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428334830?lang=zh_cn&edition=full","pubTime":"2024-04-17 09:30","pubTimestamp":1713317433,"startTime":"0","endTime":"0","summary":"4月16日,北向资金减持诺泰生物22.81万股连续3日减持。截止当日收盘,沪股通共持有诺泰生物434.80万股,占流通股2.97%。沪股通减持金额前五个股分别为宇通客车、中国石油、中国神华、万华化学、中信银行。诺泰生物近5个交易日下跌4.81%,沪股通累计增持138.18万股;近20个交易日下跌6.98%,沪股通累计增持221.21万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170937158b2ca654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170937158b2ca654&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427209850","title":"减肥药概念盘中跳水,诺泰生物跌0.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427209850","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427209850?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:42","pubTimestamp":1713231743,"startTime":"0","endTime":"0","summary":"04月16日,减肥药概念盘中跳水,截至09点42分,减肥药概念整体指数下跌0.54%,报848.350点。从个股上来看,该概念的成分股中,诺泰生物跌0.75%,甘李药业、双鹭药业跌幅居前。从资金上来看,截止发稿,减肥药概念主力净流入为-2614.68万,其中华东医药受到资金热捧,主力净流入178.30万;拉长时间线来看,该板块近20日主力资金净流入-39.78亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160942237920bd3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160942237920bd3a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427073252","title":"诺泰生物(688076)多肽赛道龙头企业,下游需求强劲成长空间广阔","url":"https://stock-news.laohu8.com/highlight/detail?id=2427073252","media":"开源证券","top":-1,"share":"https://www.laohu8.com/m/news/2427073252?lang=zh_cn&edition=full","pubTime":"2024-04-15 18:16","pubTimestamp":1713176219,"startTime":"0","endTime":"0","summary":"全产业链布局的多肽赛道龙头企业,自选产品业务快速放量打开成长空间 诺泰生物 是国内多肽赛道龙头企业,已布局多肽上下游全产业链,并通过收购澳赛诺拓展定制研发生产业务。多肽原料药产能已达吨级规模,下游需求持续提升增长势头强劲公司持续推进多肽产能建设,目前多肽原料药产能已达吨级规模,601多肽原料药车间预计于2025年底投产,届时产能将达数吨级规模。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415183022877f1a15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415183022877f1a15&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427802235","title":"开源证券给予诺泰生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2427802235","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2427802235?lang=zh_cn&edition=full","pubTime":"2024-04-15 17:17","pubTimestamp":1713172620,"startTime":"0","endTime":"0","summary":"开源证券04月15日发布研报称,给予诺泰生物(688076.SH,最新价:51.75元)买入评级。评级理由主要包括:1)全产业链布局的多肽赛道龙头企业,自选产品业务快速放量打开成长空间;2)GLP-1重磅单品频出,催化多肽产业链蓬勃发展;3)多肽原料药产能已达吨级规模,下游需求持续提升增长势头强劲。风险提示:行业竞争加剧、自选产品放量不及预期、产能落地不及预期。AI点评:诺泰生物近一个月获得7份券商研报关注,买入5家,增持1家,平均目标价为62.08元,与最新价51.75元相比,高10.33元,目标均价涨幅19.96%。(文章来源:每日经济新闻)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415171931877ed9f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415171931877ed9f9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426088227","title":"诺泰生物大幅上涨 近半年6家券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2426088227","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2426088227?lang=zh_cn&edition=full","pubTime":"2024-04-12 13:35","pubTimestamp":1712900100,"startTime":"0","endTime":"0","summary":"04月12日,诺泰生物股价大幅上涨,截至13点35分,诺泰生物上涨5.02%,报52.67元/股,成交1.65亿元,换手率2.20%。资金动向截止发稿,诺泰生物获得主力净流出3043万元,其中超大单流出1645万元,大单流出1396万元。北向资金方面,诺泰生物04月11日获得北向资金增持88.08万股,连续3日增持,截至04月11日,北向资金当前共持有诺泰生物496.75万股,市值2.62亿元,持股占流通股比为3.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121335097a525064&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121335097a525064&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-05-20","address":"江苏省连云港市连云区经济技术开发区临浦路28号","stockEarnings":[{"period":"1week","weight":0.0145},{"period":"1month","weight":0.06},{"period":"3month","weight":0.378},{"period":"6month","weight":0.2091},{"period":"1year","weight":0.8274},{"period":"ytd","weight":0.2465}],"companyName":"江苏诺泰澳赛诺生物制药股份有限公司","boardCode":"AI0027","perCapita":"14675股","boardName":"医药制造业","registeredCapital":"21318万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 江苏诺泰澳赛诺生物制药股份有限公司是一家聚焦多肽药物及小分子化药进行自主研发与定制研发生产相结合的生物医药企业。公司的主要产品为阿托伐他汀钙片、氨氯地平阿托伐他汀钙片、利拉鲁肽、司美格鲁肽、苯甲酸阿格列汀、比伐芦定、依替巴肽、醋酸兰瑞肽、醋酸奥曲肽、磷酸奥司他韦、胸腺法新、GLP-1/GIP/GCG受体多靶点激动剂1类新药、氟维司群。","serverTime":1714849168526,"listedPrice":15.57,"stockholders":"9974人(较上一季度减少3.67%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺泰生物(688076)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺泰生物(688076)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺泰生物,688076,诺泰生物股票,诺泰生物股票老虎,诺泰生物股票老虎国际,诺泰生物行情,诺泰生物股票行情,诺泰生物股价,诺泰生物股市,诺泰生物股票价格,诺泰生物股票交易,诺泰生物股票购买,诺泰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺泰生物(688076)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺泰生物(688076)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}